Infinant Health
PrivateLast Round
Early Stage
VC
Jun 8, 2026
Total Funding Raised
$135M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Infinant Health operates in Healthcare & Life Sciences and is based in Sacramento, California. Its latest recorded funding round was an Early Stage VC round in June 2026.
Infinant Health is a biotechnology company that develops microbiome-based therapeutics and products to improve infant health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, D2C Brands
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinant Health Comparables
Compare Infinant Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infant Bacterial Therapeutics | 81% | |
| Siolta Therapeutics | 66% | |
| Begin Health | 65% |
For institutional investors. Book with your work email.
Infinant Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 8, 2026 | ||||
| Series D | May 25, 2021 | ||||
| Series C | Jun 13, 2018 | ||||
| Series B | May 30, 2017 | ||||
| Series A | Aug 17, 2015 | ||||
Seed | Aug 15, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Infinant Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series D, Series A, Series C |
| abrdn Inc. | Early Stage VC |
| Manna Tree | Series D |
| Gates Foundation | Series C |
| Acre Venture Partners | Series B, Series C, Series D |
| Alta Ventures | Series C |
| Bill & Melinda Gates Foundation | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
$39.2M raised in early stage VC funding.
- Feb 8, 2021
$65M round led by Cargill and Manna Tree.
For institutional investors. Book with your work email.
Infinant Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Infinant Health's valuation, stock price, and market status.
Is Infinant Health a public or private company?
Infinant Health is a private company.
What is the current stock price of Infinant Health?
Infinant Health is a private company, so its shares have no public market price. Caplight tracks Infinant Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Infinant Health worth (valuation)?
Valuation information for Infinant Health is not publicly available.
Can I buy Infinant Health stock?
Infinant Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Infinant Health's last funding round?
Infinant Health's most recent funding round was Early Stage VC on June 8, 2026.
Who are the main investors in Infinant Health?
Key investors in Infinant Health include Horizons Ventures, Manna Tree, Gates Foundation, Bill & Melinda Gates Foundation, Cargill.
Will Infinant Health IPO soon?
No public IPO plans have been announced for Infinant Health.
How can I track Infinant Health secondary market activity?
Caplight tracks bids, offers, and trades in Infinant Health's shares on secondary markets.